Скачать или смотреть Life with Glanzmann’s thrombasthenia: the Glanzmann’s 360 study

Glanzmann’s thrombasthenia (GT) is a rare bleeding disorder which is difficult to treat. Kate Khair, PhD, Haemnet, London, UK, shares insights gained from the Glanzmann’s 360 study (ISRCTN 63686338), which aims to understand what life is like for patients with GT using quality of life (QoL) assessments and interviews with patients. Dr Khair highlights the importance of this study in the development of new treatments. This interview took place at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Montréal, Canada.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.